Showing results (21-30 of 123) with videos related to

Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Doxorubicin compared with related compounds in a nude mouse model for human ovarian cancerE Boven, H M Schlüper, C A Erkelens, et al.
Cell Biophysics|January 1, 1994
Comparison of two anthracycline-based prodrugs for activation by a monoclonal antibody-beta-glucuronidase conjugate in the specific treatment of cancerH J Haisma, M van Muijen, H M Pinedo, et al.
Cancer|January 1, 1984
Complete response of metastasized adrenal cortical carcinoma with o,p'-DDD. Case report and literature reviewE Boven, J B Vermorken, H van Slooten, et al.
Journal of Immunological Methods|September 18, 1992
Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies directed against intracellular antigensH J Haisma, H M Pinedo, C A Silva, et al.
International Journal of Cancer|February 1, 1992
Influence of dose and schedule on the therapeutic efficacy of 131I-labelled monoclonal antibody 139H2 in a human ovarian cancer xenograft modelC F Molthoff, H M Pinedo, H M Schlüper, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1988
Preclinical phase II studies in human tumor lines: a European multicenter studyE Boven, B Winograd, O Fodstad, et al.
Cancer Research|October 1, 1985
Specific killing of human melanoma cells by 125I-labeled 9.2.27 monoclonal antibodyT Lindmo, E Boven, J B Mitchell, et al.
The Netherlands Journal of Medicine|November 24, 2004
FOLFOX3 in heavily pretreated patients with metastatic colorectal cancerN Croles, C H Smorenburg, C J van Groeningen, et al.
British Journal of Cancer|July 1, 1993
The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancerE Boven, H Schipper, C A Erkelens, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1992
Experimental and clinical analysis of the characteristics of a chimeric monoclonal antibody, MOv18, reactive with an ovarian cancer-associated antigenC F Molthoff, M R Buist, P Kenemans, et al.
Pageof 13